Inventor · disambiguated record
Eckart Bartnik
Also filed as: BARTNIK ECKART
16 granted patents·5 pending applications·481 citations·filing 1995–2020
94Inventor score
Top patents by PatentIndex Score
21 records- 0191US5817742APolymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agentsHOECHST AG·Filed 1995·Granted Oct 6, 1998·107 cites·20 claims
- 0289US5693621AMalonic acid derivatives having antiadhesive propertiesHOECHST AG·Filed 1995·Granted Dec 2, 1997·97 cites·20 claims
- 0387US6136790ACarbohydrate mimetics having antiadhesive propertiesGLYCOREX AB·Filed 1997·Granted Oct 24, 2000·70 cites·38 claims
- 0487US5858994ACarbohydrate conjugates as inhibitors of cell adhesionHOECHST AG·Filed 1995·Granted Jan 12, 1999·79 cites·34 claims
- 0582US6573277B2Cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acidsFiled 2001·Granted Jun 3, 2003·15 cites·11 claims
- 0680US6815440B2Cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acidsAVENTIS PHARMA GMBH·Filed 2003·Granted Nov 9, 2004·12 cites·19 claims
- 0779US5811405AMultiply fucosylated dicarboxylic acids possessing antiadhesive propertiesHOECHST AG·Filed 1997·Granted Sep 22, 1998·55 cites·30 claims
- 0871US6207672B1Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acidsAVENTIS PHARMA GMBH·Filed 1996·Granted Mar 27, 2001·25 cites·12 claims
- 0965US7364887B2Use of PAK inhibitor for the treatment of a joint diseaseSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Apr 29, 2008·3 cites·5 claims
- 1053US5872209AArtificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systemsHOECHST AG·Filed 1997·Granted Feb 16, 1999·7 cites·7 claims
- 1150US8187828B2Use of PAK inhibitor for the treatment of a joint diseaseBARRADEAU SEBASTIAN·Filed 2008·Granted May 29, 2012·0 cites·10 claims
- 1250US6500811B2Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and useAVENTIS PHARMA GMBH·Filed 2001·Granted Dec 31, 2002·0 cites·24 claims
- 1350US2017050988A1Dotam derivatives for therapeutic useSANOFI SA·Filed 2014·Application pending·0 cites
- 1446US10660852B2Expression and folding in the manufacturing process of CD-RAP by using a CD-RAP precursor proteinBIONET PHARMA GMBH·Filed 2016·Granted May 26, 2020·0 cites·13 claims
- 1545US6406894B1Process for preparing polyvalent and physiologically degradable carbohydrate-containing polymers by enzymatic glycosylation reactions and the use thereof for preparing carbohydrate building blocksGLYCOREX AB·Filed 1997·Granted Jun 18, 2002·6 cites·17 claims
- 1644US6235727B1Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and useAVENTIS PHARMA GMBH·Filed 1999·Granted May 22, 2001·4 cites·22 claims
- 1744US2020268663A1Expression and folding in the manufacturing process of cd-rap by using a cd-rap precursor proteinBIONET PHARMA GMBH·Filed 2020·Application pending·0 cites
- 1844US2004220148A15-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonistsAVENTIS PHARMA GMBH·Filed 2003·Application pending·0 cites
- 1935US2002128226A1Enoxaparin and methods of its useFiled 2001·Application pending·0 cites
- 2035US2008274487A1Use of Serum/Glucocorticoid-Regulated KinaseSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Application pending·0 cites
- 2134US6180334B1Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systemsAVENTIS PHARMA GMBH·Filed 1998·Granted Jan 30, 2001·1 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Eckart Bartnik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →